Topic: Rochelle Walensky

The U.S. Centers for Disease Control and Prevention on Tuesday authorized Novavax's COVID-19 vaccine for adults.

Efforts to curb the spread of the monkeypox virus in the United States are being complicated by more than COVID-19, public health experts told UPI.

The U.S. Centers for Disease Control and Preventions' independent advisory panel recommended Thursday to allow Moderna's COVID-19 vaccine for use in children between 6 and 17, the public health agency confirmed.

President Joe Biden will give an update on Tuesday about the availablility of COVID-19 vaccines for children under the age of 5, which was the last segment of the population to get authorization for the shots.

COVID-19 vaccines will be available for children under 5 for the first time following their approval on Saturday by the Centers for Disease Control and Prevention. 

The Food and Drug Administration on Friday expanded the emergency use authorization of Pfizer-BioNTech and Moderna COVID-19 vaccines to include children as young as 6 months.

Monkeypox symptoms can often be mistaken for symptoms of some STDs, making the virus difficult to detect, the Centers for Disease Control and Prevention warned Friday.

Children under five could begin getting COVID-19 vaccine shots as soon as June 20, health officials announced Thursday.

The U.S. Centers for Disease Control and Prevention confirmed on Thursday nine cases of monkeypox across seven states.

White House COVID-19 response coordinator Dr. Ashish Jha said the FDA could decide on whether to make vaccine booster shots for children younger than 5 in "the next few weeks."